Ishares U.s. Pharmaceuticals Etf Technicals
Ishares U.s. Pharmaceuticals Etf logo

Ishares U.s. Pharmaceuticals Etf(ALLUS_IHE)

$175.00-0.55%

Market is closed - opens 7 PM, 12 Jun 2023

Insights

  • Ishares U.s. Pharmaceuticals Etf is currently in a neutral trading position according to technical analysis indicators.
  • Based on analysis of the Oscillators technical indicator, the current market trend for Ishares U.s. Pharmaceuticals Etf stock suggests that it is range bound and no decision can be made based on this information
  • Based on analysis of the Moving Averages technical indicator, Ishares U.s. Pharmaceuticals Etf stock is in a downtrend↘️
  • Based on analysis of the Pivot Points, the current market trend for Ishares U.s. Pharmaceuticals Etf stock suggests that it is a good time to buy

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name

Value

Action

Relative Strength Index
46.38
Neutral
Stochastic
24.21, 14.23
Neutral
Ultimate Oscillator
50.71
Neutral
Stochastic Relative Strength Index
59.08, 31.75
Neutral
Moving Average Convergence Divergence
-1.92, -1.59
Neutral

Moving Averages

Simple Moving Average

Period (Days)

Value

Action

10
173.79
Sell
20
176.41
Sell
50
178.05
Sell

Exponential Moving Average

Period (Days)

Value

Action

10
173.89
Sell
20
175.54
Sell
50
177.5
Sell

Volume Weighted Moving Average

Period (Days)

Value

Action

10
173.26
Neutral
20
176.35
Neutral
50
177.64
Neutral

Double Exponential Moving Average

Period (Days)

Value

Action

10
172.22
Sell
20
173.12
Sell
50
175.63
Sell

Triple Exponential Moving Average

Period (Days)

Value

Action

10
172.43
Buy
20
171.7
Sell
50
174.79
Sell

Pivot

Pivot

Value

Resistance L3
177.78
Resistance L2
176.55
Resistance L1
175.9
Pivot Point
174.67
Support L1
174.02
Support L2
172.79
Support L3
172.13

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.